Polo-like kinase 1 (PLK1) is a biomarker that can be used to evaluate the biological behavior and prognosis of the colorectal cancers [51] and is considered as an oncogene by cell cycle progression [52]. The gene discussed is PLK1; the disease is colorectal cancer.